Skip to main content
SCYNEXIS, Inc. (SCYX)
NASDAQ: SCYX · Real-Time Price · USD
0.750
+0.045 (6.38%)
Feb 27, 2026, 4:00 PM EST - Market closed

SCYNEXIS Revenue

SCYNEXIS had revenue of $334.00K in the quarter ending September 30, 2025, a decrease of -49.39%. This brings the company's revenue in the last twelve months to $2.93M, down -65.77% year-over-year. In the year 2024, SCYNEXIS had annual revenue of $3.75M, down -97.33%.

Revenue (ttm)
$2.93M
Revenue Growth
-65.77%
P/S Ratio
10.73
Revenue / Employee
$104,714
Employees
28
Market Cap
31.47M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20243.75M-136.40M-97.33%
Dec 31, 2023140.14M135.05M2,652.72%
Dec 31, 20225.09M-8.07M-61.32%
Dec 31, 202113.16M--
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Rockwell Medical 75.58M
InterCure 72.16M
Aytu BioPharma 62.64M
Cumberland Pharmaceuticals 41.28M
Zhengye Biotechnology Holding 21.46M
TherapeuticsMD 2.80M
BioXcel Therapeutics 752.00K
Talphera 28.00K
Revenue Rankings

SCYX News

More News